
As of 30-JUN-2026, promoters held 34.53% of Sai Life Sciences (-0.08 pp from 31-MAR-2026), foreign institutional investors 19.65%, domestic institutions 32.71% and the public 13.11%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Promoters held 34.53% of Sai Life Sciences as of 30-JUN-2026, down 0.08 pp from 34.61% in 31-MAR-2026.
Foreign institutional investors held 19.65% of Sai Life Sciences as of 30-JUN-2026, a change of -1.52 pp from the previous quarter.
Domestic institutional investors, including mutual funds and insurers, held 32.71% of Sai Life Sciences as of 30-JUN-2026 (+1.17 pp from the previous quarter).
As of 30-JUN-2026, Sai Life Sciences' shareholders were promoters (34.53%), foreign institutional investors 19.65%, domestic institutions 32.71% and the public 13.11%, as filed with the stock exchanges.
Track SAILIFE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.